1
|
Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.
|
Development
|
1996
|
2.88
|
2
|
Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat.
|
Neuroendocrinology
|
1999
|
1.97
|
3
|
Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.
|
Curr Opin Cell Biol
|
1998
|
1.95
|
4
|
Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas.
|
Cancer Res
|
1995
|
1.93
|
5
|
The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers.
|
Am J Pathol
|
1994
|
1.79
|
6
|
Cancer invasion and tissue remodeling--cooperation of protease systems and cell types.
|
APMIS
|
1999
|
1.77
|
7
|
Neutrophils express tumor necrosis factor-alpha during mouse skin wound healing.
|
J Invest Dermatol
|
1995
|
1.60
|
8
|
The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility.
|
J Biol Chem
|
1995
|
1.45
|
9
|
Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
|
Clin Exp Metastasis
|
1996
|
1.27
|
10
|
The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake.
|
Nat Med
|
2000
|
1.17
|
11
|
Regulation of pancreatic beta-cell mass and proliferation by SOCS-3.
|
J Mol Endocrinol
|
2005
|
1.10
|
12
|
A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors.
|
Int J Cancer
|
1994
|
1.04
|
13
|
Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.
|
EMBO J
|
1991
|
0.99
|
14
|
Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model.
|
Br J Dermatol
|
2008
|
0.98
|
15
|
Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications.
|
Biol Chem Hoppe Seyler
|
1995
|
0.96
|
16
|
Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells.
|
J Biol Chem
|
1991
|
0.93
|
17
|
Plasminogen and wound healing.
|
Nat Med
|
1996
|
0.90
|
18
|
Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer.
|
Cancer Treat Res
|
1994
|
0.89
|
19
|
Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling.
|
Biochem J
|
2001
|
0.87
|
20
|
The nude mouse as an in vivo model for human breast cancer invasion and metastasis.
|
Breast Cancer Res Treat
|
1993
|
0.87
|
21
|
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice.
|
J Thromb Haemost
|
2007
|
0.83
|
22
|
Synergistic effect of the human GLP-1 analogue liraglutide and a dual PPARalpha/gamma agonist on glycaemic control in Zucker diabetic fatty rats.
|
Diabetes Obes Metab
|
2009
|
0.82
|
23
|
Proteoglycan expression in the normal rat kidney.
|
Nephron
|
1997
|
0.80
|
24
|
House dust mite allergy and anti-mite measures in the indoor environment.
|
Allergy
|
1991
|
0.78
|
25
|
The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats.
|
J Endocrinol
|
2000
|
0.77
|
26
|
Adipogenic and orexigenic effects of the ghrelin-receptor ligand tabimorelin are diminished in leptin-signalling-deficient ZDF rats.
|
Eur J Endocrinol
|
2004
|
0.77
|
27
|
Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.
|
J Invest Dermatol
|
1996
|
0.77
|
28
|
Effects of growth hormone and its secretagogues on bone.
|
Endocrine
|
2001
|
0.76
|
29
|
Healing hormones.
|
Nat Med
|
1997
|
0.75
|
30
|
[The significance of tobacco smoking for asthma and rhinitis].
|
Ugeskr Laeger
|
1983
|
0.75
|